cirsimaritin has been researched along with interleukin-8 in 1 studies
| Studies (cirsimaritin) | Trials (cirsimaritin) | Recent Studies (post-2010) (cirsimaritin) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 49 | 0 | 21 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, H; Li, Y; Ma, L; Ma, X; Wang, H; Wu, S; Yan, H; Yin, J | 1 |
1 other study(ies) available for cirsimaritin and interleukin-8
| Article | Year |
|---|---|
Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Topics: Animals; Antiviral Agents; Artemisia; Cyclooxygenase 2; Dogs; Dose-Response Relationship, Drug; Flavones; Gene Expression Regulation; Hemagglutination Inhibition Tests; Host-Pathogen Interactions; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Interleukin-10; Interleukin-1beta; Interleukin-8; Madin Darby Canine Kidney Cells; Neuraminidase; Plant Extracts; Signal Transduction; THP-1 Cells; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Viral Load; Viral Proteins; Virus Replication | 2018 |